We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHAQ.U
151
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$1.63M 0.06%
153,960
– –
GNLN icon
152
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
CRIS icon
153
CALL
Curis
CRIS
$3.49M
$1.57M 0.06%
+478
New +$574K
FOLD
154
DELISTED
Amicus Therapeutics
FOLD
$1.34M 0.05%
58,200
-100,000
-63% -$2.05M
EPIX
155
DELISTED
ESSA Pharma
EPIX
$1.31M 0.05%
110,149
+90,149
+451% +$635K
NKTR icon
156
Nektar Therapeutics
NKTR
$2.57B
$1.31M 0.05%
+5,140
New +$1.33M
OBIO icon
157
Orchestra BioMed
OBIO
$266M
$1.28M 0.05%
100,000
– –
NKTX icon
158
Nkarta
NKTX
$171M
$1.23M 0.04%
+20,000
New +$831K
TGTX icon
159
TG Therapeutics
TGTX
$7.58B
$1.2M 0.04%
+23,029
New +$778K
SGTX
160
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$1.19M 0.04%
+1,902
New +$863K
DCTH icon
161
Delcath Systems
DCTH
$594M
$1.17M 0.04%
+65,000
New +$891K
CALA
162
CALL
DELISTED
Calithera Biosciences, Inc
CALA
$1.08M 0.04%
+11,000
New +$964K
NNOX icon
163
PUT
Nano X Imaging
NNOX
$71M
$913K 0.03%
+20,000
New +$816K
SENS icon
164
CALL
Senseonics Holdings Inc
SENS
$419M
$872K 0.03%
+50,000
New +$435K
EOLS icon
165
CALL
Evolus
EOLS
$536M
$672K 0.02%
200,000
– –
FULC icon
166
Fulcrum Therapeutics
FULC
$284M
$653K 0.02%
+55,734
New +$630K
ACRS icon
167
CALL
Aclaris Therapeutics
ACRS
$860M
$647K 0.02%
+100,000
New +$422K
AFMD
168
DELISTED
Affimed
AFMD
$582K 0.02%
+10,000
New +$471K
KROS icon
169
Keros Therapeutics
KROS
$222M
$353K 0.01%
+5,000
New +$315K
ACRS icon
170
Aclaris Therapeutics
ACRS
$860M
$324K 0.01%
+50,000
New +$211K
SRRA
171
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$304K 0.01%
18,940
– –
APVO icon
172
Aptevo Therapeutics
APVO
$5.31M
– –
0
– –
HARP
173
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$169K 0.01%
+1,020
New +$158K
MAPSW
174
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$164K 0.01%
50,000
– –
PRFX icon
175
PRF Technologies Ltd
PRFX
$3.13M
$45K ﹤0.01%
+8
New +$43.9K
5 6
7
8 9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.